rs141263564
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_025137.4(SPG11):c.6598A>T(p.Lys2200*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000285 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_025137.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPG11 | NM_025137.4 | c.6598A>T | p.Lys2200* | stop_gained | Exon 36 of 40 | ENST00000261866.12 | NP_079413.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152114Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251402Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135880
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461820Hom.: 0 Cov.: 34 AF XY: 0.0000344 AC XY: 25AN XY: 727218
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152114Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74308
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 11;C1865864:Amyotrophic lateral sclerosis type 5;C5569024:Charcot-Marie-Tooth disease axonal type 2X Pathogenic:2
- -
- -
not provided Pathogenic:2
PM2, PM3, PVS1 -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31589614, 23733235, 33059505) -
Hereditary spastic paraplegia 11 Pathogenic:2
- -
This sequence change creates a premature translational stop signal (p.Lys2200*) in the SPG11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG11 are known to be pathogenic (PMID: 19105190, 20110243, 22154821, 26556829). This variant is present in population databases (rs141263564, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with hereditary spastic paraplegia (PMID: 23733235). ClinVar contains an entry for this variant (Variation ID: 572602). For these reasons, this variant has been classified as Pathogenic. -
SPG11-related disorder Pathogenic:1
The SPG11 c.6598A>T variant is predicted to result in premature protein termination (p.Lys2200*). This variant was reported in the compound heterozygous state with another loss-of-function variant in two patients with autosomal recessive spastic paraplegia (Yoon et al. 2013. PubMed ID: 23733235; Carrasco Salas et al. 2022. PubMed ID: 33059505). This variant is reported in 0.0039% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Nonsense variants in SPG11 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Hereditary spastic paraplegia Pathogenic:1
- -
Early-onset Parkinson disease 20 Pathogenic:1
- -
Charcot-Marie-Tooth disease axonal type 2X Pathogenic:1
Variant confirmed as disease-causing by referring clinical team -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at